All Type of News
CoQ10 bulk market slump continues
Co-enzyme Q10 (CoQ10) makers are expected to show their worst performances in the second quarter of the year, with only a slim hope of recovery in the near future.
Prices of CoQ10 have been stagnant since they reac...
Ahngook to set up research center for natural products
Ahngook Pharm said recently that it will establish another research center to step up its efforts to develop higher value-added preparations by evaluating the usefulness of a
variety of natural products in collabora...
Government vows to enhance competitiveness of service market
The government plans to enhance competitiveness and productivity of the service sector and create more jobs, said an official from the Ministry of Finance and Economy on July 30.
To this end, the government has a p...
Government seeks passage of corporate pharmacy
A revision bill aiming at establishing a corporate pharmacy is likely to pass through the National Assembly next February, according to the Ministry of Finance and Economy.
The bill, which was initially proposed by...
CJ joins anti-obesity market
CJ Corporation has jumped onto the bandwagon of sibutramine market for which demand is growing fast.
CJ said on August 1 that it launched Diatramine (sibutramine) capsule as major competitors Hanmi Pharm, Daewoong ...
Yuhan shares once hit 200,000 won
Shares of Yuhan Corporation, one of the leading pharmaceutical firms in Korea, briefly surpassed 200,000-won level on August 3 thanks to robust sales of Levanex, a homegrown antiulcerant, opening a new chapter for the...
Government bans plural prescription on same medicine
Doctors are obliged to prescribe a high-content medicine from this month instead of plural low-content one, according to the Ministry of Health and Welfare on July 31.
The ministry said that under the plan, doctors...
WithPharm official wanted for embezzlement
WithPharm said on August 6 it plans to sue an official who allegedly embezzled its official funds by using his position at the company.
He allegedly attracted funds from the dishonored bill to invest in real estate...
KFDA approved Novartis' Lucentis, a vision recovery therapy.
The KFDA has approved Lucentis (ranibizumab) injectable drug filed by Novartis Korea for the treatment of wet age-related macular degeneration (AMD), which will be the first therapeutic drug ever sold in Korea.
AMD...
Yungjin stock price to close maximum gains on July 30.
A closing stock price of Yungjin on July 30 showed a maximum gain at 2,290 won per share, which was 295 won more hike to the previous day.
Yungjin officially disclosed an exaggerated accounting of the revenue for 3...
